bpc-157 bioavailability oral vs subcutaneous injection Peptides: FAQs on Bioavailability, Safety, and Clinical Use bpc-157 oral vs injection dosing

A small amount (approximately 1% of the total amount ingested) is absorbed by simple diffusion, but this mechanism is adequate only with very large doses

caution in methylation disorders (use only under supervision) No known drug interactions with oral medications, but B12 may mask B9 (folate) deficiencycombined B-vitamin status should be assessed periodically

People who have Allergies to methylcobalamin or cyanocobalamin liver or kidney disease If you have Eye issues like Lebers disease A recent infection If consuming bone marrow medication You should consult your medical consultant or doctor about the above conditions before getting B12 injections

The same is true for weight loss

Physio., 581(pt2), 431-444, 2007

We do not treat BPC-157 as a long-term medication